ABSTRACT
Acinetobacter baumannii is one of the world’s most problematic nosocomial pathogens. The combination of its intrinsic resistance and ability to acquire resistance markers allow this organism to adjust to antibiotic treatment. Despite being the primary barrier against antibiotic stress, our understanding of the A. baumannii membrane composition and its impact on resistance remains limited. In this study, we explored how the incorporation of host-derived polyunsaturated fatty acids (PUFAs) is associated with increased antibiotic susceptibility. Functional analyses of primary A. baumannii efflux systems indicated that AdeB-mediated antibiotic resistance was impacted by PUFA treatment. Molecular dynamics simulations of AdeB identified a specific morphological disruption of AdeB when positioned in the PUFA-enriched membrane. Collectively, we have shown that PUFAs can impact antibiotic efficacy via a vital relationship with antibiotic efflux pumps. Furthermore, this work has revealed that A. baumannii’s unconditional desire for fatty acids may present a possible weakness in its multidrug resistance capacity.
KEYWORDS: bacterial, host lipids, antibiotics, resistance, RND efflux
OBSERVATION
Acinetobacter baumannii is one of the world’s most notorious multidrug resistant pathogens (1, 2), yet how it responds to host-mediated stress is poorly understood. Previous reports have shown that this human pathogen displays susceptibly to host-derived omega-3 polyunsaturated fatty acids (PUFAs), such as docosahexaenoic acid (DHA) (3, 4). Here, we examined the transcriptomic responses to 0.25 mM DHA stress to identify possible genetic traits responsible for these outcomes. Although plasma DHA concentrations range from 0.1 to 0.2 mM in humans on a typical Western diet (5, 6), this can increase to levels greater than 0.4 mM DHA in populations with higher marine fish oil intake (7). Differential expression analyses revealed transcripts for 53 and 32 genes to be of higher and lower abundance, respectively (≥2-fold change, P ≤ 0.05), in DHA treated compared to untreated A. baumannii AB5075_UW cells (see Table S1 in the supplemental material). Among the most downregulated genes were those coding for two putative oxidoreductases, ABUW_3843 (5.29-fold) and ABUW_1104 (2.44-fold) (Fig. 1A; see Fig. S1A to C in the supplemental material), which are likely to assist in the electron transport required for their cotranscribed fatty acid desaturases. This is likely to be a specific response to restrict the introduction of more double bonds in acyl chains following PUFA treatment. Consistently, an increase in DHA susceptibility in the repressor mutant of this cluster was observed (Fig. S1D). Despite minimizing the exposure to DHA, the transcriptomic analyses also revealed potential general stress responses. A homologue of the Escherichia coli stress tolerance gene ygiW was significantly downregulated 4.68-fold. Further, a total of 18 genes associated with iron utilization were significantly downregulated (Fig. 1A), which could not be linked directly to fatty acid homeostasis. A number of genes with putative roles in ω-oxidation were found to be significantly upregulated upon DHA treatment (Fig. 1A). The resulting product of the ω-oxidation pathway, fatty dicarboxylic acids, can be catabolized by β-oxidation or dicarboxylate catabolic (dca) pathways (8), and several putative components in both these pathways were upregulated under DHA stress. A predicted long-chain fatty acid transporter gene (fadL; ABUW_0724) was among the upregulated genes of the β-oxidation pathway. Importantly, fadL mutants in either the A. baumannii AB5075_UW or ATCC 17978 background displayed enhanced tolerance to DHA stress (Fig. 1B; Fig. S1). Although transcriptomic profiling showed the downregulation of two desaturases to restrict introduction of double bonds following DHA treatment, it also revealed the upregulation of fadL. This somewhat greedy and unconditional acquisition of energy-rich DHA has detrimental impacts on its fitness. Unlike A. baumannii, which can be represented in a vast array of environmental habitats, Streptococcus pneumoniae is fully host adapted and is attuned to the diligent acquisition of distinct fatty acids in the host environment, which is facilitated by the concerted action of having selective proteins (FakB1, saturated FAs; FakB2 monounsaturated FAs; FakB3, PUFAs), as well as appropriate transcriptional regulation of these systems (9, 10).
Considering PUFA incorporation affects A. baumannii membrane permeability (4), we examined antimicrobial susceptibility of A. baumannii strains AB5075_UW and ATCC 17978 with or without DHA supplementation (Fig. 1C). The presence of subinhibitory amounts of DHA resulted in a 4- to 8-fold decrease in aminoglycoside resistance (gentamicin and streptomycin, respectively) and 2-fold decrease in chloramphenicol resistance in strain AB5075_UW. These differences were less dramatic in the more-antibiotic-susceptible strain ATCC 17978, where only 2-fold reductions were observed for gentamicin and chloramphenicol following cotreatment with DHA. Although commonly known for their ability to interact with phospholipids, resistance to macrolides (erythromycin and azithromycin) was not affected by PUFA treatment. In addition to altering antibiotic resistance, we examined the impact of PUFA supplementation on oxidative stress tolerance in strain AB5075_UW and revealed that PUFA treatment impacted tolerance to paraquat, which induces the formation of intracellular superoxide stress (see Fig. S2 in the supplemental material). Contrastingly, PUFA-treated bacteria were not more susceptible to exogenously supplemented hydrogen peroxide compared to untreated bacteria (Fig. S2). Examination of the impact of DHA upon gentamicin or chloramphenicol susceptibility in a fadL mutant in either an AB5075_UW or ATCC 17978 background revealed that increased susceptibility to these compounds occurs primarily following DHA uptake into the cell (Fig. 1D). In contrast to A. baumannii, no dramatic changes (≤2-fold) in antibiotic susceptibility following DHA treatment were seen in the Gram-positive bacterium, Streptococcus pneumoniae (see Table S2 in the supplemental material). Hence, our study supports the identification of a plausible pathogen-specific Achilles’ heel, this being the active acquisition of DHA by A. baumannii and the subsequent increase in antibiotic susceptibility.
Considering the roles of resistance-nodulation-cell division (RND) efflux systems in lipid homeostasis and DHA resistance (4, 11, 12), we studied the efflux activities of AdeB and AdeJ in A. baumannii with and without omega-3 PUFA enrichment. We found that the specific roles of AdeB in gentamicin and pentamidine resistance were impacted by DHA treatment, as the resistance decreased to a greater extent when AdeB was present (i.e., in wild-type or adeJ::T26 cells) than in the adeB::T26 mutant (Fig. 2A and B). To delineate the relative impact of DHA on AdeJ efflux activity, we examined the ethidium bromide (EtBr) efflux potential, by analyzing the cells with and without treatment with the protonophore carbonyl cyanide m-chlorophenyl hydrazine (CCCP), which can indirectly prevent efflux from RND pumps by collapsing the proton motive force. We found that active efflux by AdeJ is required for preventing the accumulation of EtBr, but DHA did not negatively impact this process (Fig. 2C). Instead, the increased membrane permeability as a result of DHA incorporation required greater EtBr efflux, which was reflected in the enhanced EtBr efflux potential of DHA-treated cells.
Since RND efflux relies upon the proton motive force across the cytoplasmic membrane, we ascertained the possibility of ion leakage in the A. baumannii membrane following DHA incorporation. Lipid samples extracted from actively growing A. baumannii cells were used to generate tethered bilayer lipid membranes (tBLMs). Both tBLMs displayed typical electrochemical properties (Fig. 2D) and similar responses to the incorporation of the ion carrier valinomycin (see Table S3 in the supplemental material). These analyses illustrate that the observed dysfunction of AdeB is not a result of the membrane being compromised in its ability to retain a proton motive force following the incorporation of DHA.
Evidence is emerging that phospholipids can influence folding, structure, and function of some membrane proteins, including bacterial RND systems (13–15). To identify possible differences in AdeB and AdeJ conformations in the membrane, we studied the dynamics of AdeB and AdeJ (both modeled on the AdeB cryo-electron microscopy [cryo-EM] structure; 6OWS) in the A. baumannii phospholipid environment with and without omega-3 PUFA enrichment in coarse-grained molecular dynamics (MD) simulations. After 15 μs replicate simulations, the lipid annulus surrounding both AdeB and AdeJ was enriched with unsaturated lipids in the untreated A. baumannii membrane (Fig. 2E). PUFA-containing phospholipids were heavily localized around AdeB and AdeJ when the protein complexes were embedded in a DHA-treated A. baumannii membrane (Fig. 2E). Although the conformation of the AdeJ trimer was largely unaffected by these changes in its phospholipid environment, the conformation of AdeB displayed a dramatic shift, with the complete loss of the protein-protein interface between adjacent transmembrane domains of two AdeB protomers (Fig. 2F). When assessed in conjunction with functional assays of AdeB activity in the presence of DHA, these changes suggest a possible mechanism for disruption of the conformational cycling of AdeB required for efflux activity. Consistently, previous reports on the membrane-disrupting biocides on AdeABC have also linked a role in cell envelope integrity and AdeABC efflux activity (16). Overall, the data presented here provide insights into the interplay between the membrane lipid composition and specific RND efflux activities. Hence, our work has established a molecular basis for how the lipid bilayer composition and its biophysical properties may affect antibiotic treatment success.
Overall, this study has presented a comprehensive analysis of the antimicrobial effects of host fatty acids upon A. baumannii membrane biology. Although, omega-3 PUFA supplementation is unlikely to affect healthy individuals, those that are at increased risk of contracting bacterial infections may benefit, in particular during antibiotic treatment.
ACKNOWLEDGMENTS
We thank Arnaud Kengmo Tchoupa (University of Tübingen) for in-depth discussions.
This work was supported by the National Health and Medical Research Council (Australia) through Project Grants 1140554 to M.L.O. and 1159752 to B.A.E. This work was supported by computational resources provided by the Australian Government through National Computational Infrastructure (NCI) and the Pawsey Supercomputing Centre under the National Computational Merit Allocation Scheme. A.Y.P. was supported by an Australian National Health and Medical Research Council Practitioner Fellowship. M.Z. is a recipient of an Australian Government Research Training Program scholarship and J.K.W. is supported by a Flinders University Vice Chancellor's Strategic Scholarship.
Footnotes
Citation Zang M, MacDermott-Opeskin H, Adams FG, Naidu V, Waters JK, Carey AB, Ashenden A, McLean KT, Brazel EB, Jiang J-H, Panizza A, Trappetti C, Paton JC, Peleg AY, Köper I, Paulsen IT, Hassan KA, O’Mara ML, Eijkelkamp BA. 2021. The membrane composition defines the spatial organization and function of a major Acinetobacter baumannii drug efflux system. mBio 12:e01070-21. https://doi.org/10.1128/mBio.01070-21.
Contributor Information
Bart A. Eijkelkamp, Email: bart.eijkelkamp@flinders.edu.au.
Robert A. Bonomo, Louis Stokes Veterans Affairs Medical Center
REFERENCES
- 1.CDC. 2019. Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention, Atlanta, GA. [Google Scholar]
- 2.WHO. 2017. WHO publishes list of bacteria for which new antibiotics are urgently needed. https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed.
- 3.Eder AE, Munir SA, Hobby CR, Anderson DM, Herndon JL, Siv AW, Symes SJK, Giles DK. 2017. Exogenous polyunsaturated fatty acids (PUFAs) alter phospholipid composition, membrane permeability, biofilm formation and motility in Acinetobacter baumannii. Microbiology (Reading) 163:1626–1636. doi: 10.1099/mic.0.000556. [DOI] [PubMed] [Google Scholar]
- 4.Jiang JH, Hassan KA, Begg SL, Rupasinghe TWT, Naidu V, Pederick VG, Khorvash M, Whittall JJ, Paton JC, Paulsen IT, McDevitt CA, Peleg AY, Eijkelkamp BA. 2019. Identification of novel Acinetobacter baumannii host fatty acid stress adaptation strategies. mBio 10:e02056-18. doi: 10.1128/mBio.02056-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Calder PC. 2016. Docosahexaenoic acid. Ann Nutr Metab 69(Suppl 1):7–21. doi: 10.1159/000448262. [DOI] [PubMed] [Google Scholar]
- 6.Abdelmagid SA, Clarke SE, Nielsen DE, Badawi A, El-Sohemy A, Mutch DM, Ma DW. 2015. Comprehensive profiling of plasma fatty acid concentrations in young healthy Canadian adults. PLoS One 10:e0116195. doi: 10.1371/journal.pone.0116195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kuriki K, Nagaya T, Tokudome Y, Imaeda N, Fujiwara N, Sato J, Goto C, Ikeda M, Maki S, Tajima K, Tokudome S. 2003. Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study. J Nutr 133:3643–3650. doi: 10.1093/jn/133.11.3643. [DOI] [PubMed] [Google Scholar]
- 8.Parke D, Garcia MA, Ornston LN. 2001. Cloning and genetic characterization of dca genes required for beta-oxidation of straight-chain dicarboxylic acids in Acinetobacter sp. strain ADP1. Appl Environ Microbiol 67:4817–4827. doi: 10.1128/aem.67.10.4817-4827.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Eijkelkamp BA, Begg SL, Pederick VG, Trapetti C, Gregory MK, Whittall JJ, Paton JC, McDevitt CA. 2018. Arachidonic acid stress impacts pneumococcal fatty acid homeostasis. Front Microbiol 9:813. doi: 10.3389/fmicb.2018.00813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gullett JM, Cuypers MG, Frank MW, White SW, Rock CO. 2019. A fatty acid-binding protein of Streptococcus pneumoniae facilitates the acquisition of host polyunsaturated fatty acids. J Biol Chem 294:16416–16428. doi: 10.1074/jbc.RA119.010659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Leus IV, Weeks JW, Bonifay V, Smith L, Richardson S, Zgurskaya HI. 2018. Substrate specificities and efflux efficiencies of RND efflux pumps of Acinetobacter baumannii. J Bacteriol 200:e00049-18. doi: 10.1128/JB.00049-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Leus IV, Adamiak J, Trinh AN, Smith RD, Smith L, Richardson S, Ernst RK, Zgurskaya HI. 2020. Inactivation of AdeABC and AdeIJK efflux pumps elicits specific nonoverlapping transcriptional and phenotypic responses in Acinetobacter baumannii. Mol Microbiol 114:1049–1065. doi: 10.1111/mmi.14594. [DOI] [PubMed] [Google Scholar]
- 13.Du D, Neuberger A, Orr MW, Newman CE, Hsu PC, Samsudin F, Szewczak-Harris A, Ramos LM, Debela M, Khalid S, Storz G, Luisi BF. 2020. Interactions of a bacterial RND transporter with a transmembrane small protein in a lipid environment. Structure 28:625–634.e6. doi: 10.1016/j.str.2020.03.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Qiu W, Fu Z, Xu GG, Grassucci RA, Zhang Y, Frank J, Hendrickson WA, Guo Y. 2018. Structure and activity of lipid bilayer within a membrane-protein transporter. Proc Natl Acad Sci U S A 115:12985–12990. doi: 10.1073/pnas.1812526115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Su CC, Morgan CE, Kambakam S, Rajavel M, Scott H, Huang W, Emerson CC, Taylor DJ, Stewart PL, Bonomo RA, Yu EW. 2019. Cryo-electron microscopy structure of an Acinetobacter baumannii multidrug efflux pump. mBio 10:e01295-19. doi: 10.1128/mBio.01295-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Krishnamoorthy S, Shah BP, Lee HH, Martinez LR. 2016. Microbicides alter the expression and function of RND-type efflux pump AdeABC in biofilm-associated cells of Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 60:57–63. doi: 10.1128/AAC.01045-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.